GERD related micro-aspiration in chronic mustard-induced pulmonary disorder

Rasoul Aliannejad1, Seyed-Mehdi Hashemi-Bajgani, Asharaf Karbasi

  • 1Respiratory Diseases and TB Research Center of Guilan University of Medical Science, Razi Hospital, Rasht, Iran.

Abstract

Insights

Sulfur mustard (SM) gas exposure can cause bronchiolitis obliterans (BO). This study found that most BO patients suffer from gastro-esophageal reflux (GER), which may worsen their chronic lung disease exacerbations.

Area of Science:

  • Pulmonary Medicine
  • Toxicology
  • Gastroenterology

Background:

  • Bronchiolitis obliterans (BO) is a significant pulmonary complication following sulfur mustard (SM) gas exposure.
  • SM gas was used against Iranian civilians and military personnel during the Iran-Iraq war, leading to long-term health issues.
  • Chronic pulmonary diseases and recurrent exacerbations are common in SM-exposed individuals.

Purpose of the Study:

  • To investigate the prevalence of gastro-esophageal reflux (GER) and gastric micro-aspiration in patients with chronic pulmonary diseases after SM gas injury.
  • To assess the potential role of GER in exacerbations of lung disease in SM survivors.

Main Methods:

  • A cross-sectional study was conducted at Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Gastric micro-aspiration and GER were evaluated by analyzing bile acids, pepsin, and trypsin in bronchoalveolar lavage (BAL) fluid.
  • BAL fluid analysis included detection of bile acids, pepsin, and trypsin.

Main Results:

  • Bile acids were detected in the BAL fluid of 75% of patients (21.4% high, 53.6% low).
  • No bile was detected in only 16% of patients.
  • Pepsin and trypsin were present in the BAL fluid of all evaluated patients.

Conclusions:

  • The majority of BO patients exposed to SM exhibit signs of GER.
  • Unlike post-lung transplant BO, the typical etiologic factors for GER are absent in these patients.
  • GER is hypothesized to be an aggravating factor for exacerbations in SM-induced BO, warranting further investigation into its pathophysiological mechanisms and treatment.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation